Globe Life Inc

NYSE : GL
$168.77+0.28%Oct 16 close

Financials

Original filing

Condensed Consolidated Balance Sheets

USD · reported units.

Condensed Consolidated Balance Sheets, filing 0000320335-26-000216. USD · reported units.
Reported line itemJun 30, 2026 (current)Dec 31, 2025
Statement of Financial Position [Abstract]
Assets:
Investments:
Fixed maturities—available for sale, at fair value (amortized cost: 2026—$19,307,295; 2025—$18,820,464, allowance for credit losses: 2026— $3,297; 2025— $3,297)
Mortgage loans
Policy loans
Other long-term investments (includes: 2026—$1,097,834; 2025—$1,109,719 under the fair value option)
Short-term investments
Total investments
Cash
Accrued investment income
Other receivables
Deferred acquisition costs
Goodwill
Other assets
Total assets
Liabilities:
Future policy benefits at current discount rates: (at original discount rates: 2026—$18,454,909; 2025—$18,129,506)
Unearned and advance premium
Policy claims and other benefits payable
Other policyholders' funds
Total policy liabilities
Current and deferred income taxes
Short-term debt
Long-term debt (estimated fair value: 2026—$2,504,936; 2025—$2,225,320)
Other liabilities
Total liabilities
Commitments and Contingencies (Note 5)——
Shareholders' equity:
Preferred stock, par value $1 per share—5,000,000 shares authorized; outstanding: 0 in 2026 and 2025
Common stock, par value $1 per share—320,000,000 shares authorized; outstanding: (2026—92,218,183 issued; 2025—92,218,183 issued)
Additional paid-in-capital
Accumulated other comprehensive income (loss)
Retained earnings
Treasury stock, at cost: (2026—15,164,175 shares; 2025—13,125,082 shares)
Total shareholders' equity
Total liabilities and shareholders' equity
32 line items · 2 reported periodsOriginal filing order · parentheses indicate negative amounts

Each column reflects this filing’s presentation. Original line items and period dates are preserved.

Arithmetic validation is incomplete for this statement. Source values remain individually inspectable.